Мукополисахаридоза тип IV (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Мукополисахаридоза тип IV" in Serbian language version.
refsWebsite
Global rank
Serbian rank
5th place
12th place
doi.org (Global: 2nd place; Serbian: 4th place)
- Lowry RB, Applegarth DA, Toone JR, MacDonald E, Thunem NY (август 1990). „An update on the frequency of mucopolysaccharide syndromes in British Columbia.”. Hum Genet. 85 (3): 389—90. PMID 2118475. doi:10.1007/BF00206770..
- Lowry RB, Applegarth DA, Toone JR, MacDonald E, Thunem NY (август 1990). „An update on the frequency of mucopolysaccharide syndromes in British Columbia”. Hum Genet. 85 (3): 389—90. PMID 2118475. doi:10.1007/BF00206770..
- Nelson J (децембар 1997). „Incidence of the mucopolysaccharidoses in Northern Ireland”. Hum Genet. 101 (3): 355—8. PMID 9439667. doi:10.1007/s004390050641..
- Meikle PJ, Hopwood JJ, Clague AE, Carey WF (јануар 1999). „Prevalence of lysosomal storage disorders”. JAMA. 281 (3): 249—54. PMID 9918480. doi:10.1001/jama.281.3.249..
- Pinto R, Caseiro C, Lemos M, Lopes L, Fontes A, Ribeiro H; et al. (фебруар 2004). „Prevalence of lysosomal storage diseases in Portugal”. Eur J Hum Genet. 12 (2): 87—92. PMID 14685153. doi:10.1038/sj.ejhg.5201044..
- Tomatsu S, Montaño AM, Oikawa H, Smith M, Barrera L, Chinen Y; et al. (јун 2011). „Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment”. Curr Pharm Biotechnol. 12 (6): 931—45. PMID 21506915. doi:10.2174/138920111795542615..
- Khan S, Alméciga-Díaz CJ, Sawamoto K, Mackenzie WG, Theroux MC, Pizarro C, et al. Khan, S.; Alméciga-Díaz, C. J.; Sawamoto, K.; MacKenzie, W. G.; Theroux, M. C.; Pizarro, C.; Mason, R. W.; Orii, T.; Tomatsu, S. (2017 Jan - Feb). „Mucopolysaccharidosis IVA and glycosaminoglycans.”. Mol Genet Metab. 120 (1–2): 78—95. PMC 5293636
. PMID 27979613. doi:10.1016/j.ymgme.2016.11.007. Проверите вредност парамет(а)ра за датум: |date=(помоћ). - Hendriksz CJ, Burton B, Fleming TR, Harmatz P, Hughes D, Jones SA; et al. (новембар 2014). „Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study.”. J Inherit Metab Dis. 37 (6): 979—90. PMC 4206772 . PMID 24810369. doi:10.1007/s10545-014-9715-6..
- Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—41. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126.
- Wishart, D. S.; Knox, C.; Guo, A. C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—6. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958.
nih.gov (Global: 4th place; Serbian: 8th place)
ncbi.nlm.nih.gov
- Lowry RB, Applegarth DA, Toone JR, MacDonald E, Thunem NY (август 1990). „An update on the frequency of mucopolysaccharide syndromes in British Columbia.”. Hum Genet. 85 (3): 389—90. PMID 2118475. doi:10.1007/BF00206770..
- Lowry RB, Applegarth DA, Toone JR, MacDonald E, Thunem NY (август 1990). „An update on the frequency of mucopolysaccharide syndromes in British Columbia”. Hum Genet. 85 (3): 389—90. PMID 2118475. doi:10.1007/BF00206770..
- Nelson J (децембар 1997). „Incidence of the mucopolysaccharidoses in Northern Ireland”. Hum Genet. 101 (3): 355—8. PMID 9439667. doi:10.1007/s004390050641..
- Meikle PJ, Hopwood JJ, Clague AE, Carey WF (јануар 1999). „Prevalence of lysosomal storage disorders”. JAMA. 281 (3): 249—54. PMID 9918480. doi:10.1001/jama.281.3.249..
- Pinto R, Caseiro C, Lemos M, Lopes L, Fontes A, Ribeiro H; et al. (фебруар 2004). „Prevalence of lysosomal storage diseases in Portugal”. Eur J Hum Genet. 12 (2): 87—92. PMID 14685153. doi:10.1038/sj.ejhg.5201044..
- Tomatsu S, Montaño AM, Oikawa H, Smith M, Barrera L, Chinen Y; et al. (јун 2011). „Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment”. Curr Pharm Biotechnol. 12 (6): 931—45. PMID 21506915. doi:10.2174/138920111795542615..
- Khan S, Alméciga-Díaz CJ, Sawamoto K, Mackenzie WG, Theroux MC, Pizarro C, et al. Khan, S.; Alméciga-Díaz, C. J.; Sawamoto, K.; MacKenzie, W. G.; Theroux, M. C.; Pizarro, C.; Mason, R. W.; Orii, T.; Tomatsu, S. (2017 Jan - Feb). „Mucopolysaccharidosis IVA and glycosaminoglycans.”. Mol Genet Metab. 120 (1–2): 78—95. PMC 5293636 . PMID 27979613. doi:10.1016/j.ymgme.2016.11.007. Проверите вредност парамет(а)ра за датум:
|date=(помоћ). - Hendriksz CJ, Burton B, Fleming TR, Harmatz P, Hughes D, Jones SA; et al. (новембар 2014). „Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study.”. J Inherit Metab Dis. 37 (6): 979—90. PMC 4206772 . PMID 24810369. doi:10.1007/s10545-014-9715-6..
- Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—41. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126.
- Wishart, D. S.; Knox, C.; Guo, A. C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—6. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958.